Cannabis, CBD industry wary of looming decision on epilepsy drug

Published April 9, 2018 | By Kristen NicholsThe most disruptive product to hit the newly legal hemp industry might be one that will never be sold directly to consumers.GW Pharmaceuticals, a London-based biotech company, is awaiting a final decision from the U.S. Food and Drug Administration to produce the first cannabis-derived treatment to win approval …